The global Novel Drug Delivery Systems for Cancer Therapy market was valued at US$ 6551.3 million in 2023 and is anticipated to reach US$ 7359.5 million by 2030, witnessing a CAGR of 1.7% during the forecast period 2024-2030.

Novel Drug Delivery Systems for Cancer Therapy Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Novel Drug Delivery Systems for Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Delivery Systems for Cancer Therapy.

Report Scope

The Novel Drug Delivery Systems for Cancer Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Drug Delivery Systems for Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Novel Drug Delivery Systems for Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Novel Drug Delivery Systems for Cancer Therapy Market Report

Report Metric	Details
Report Name	Novel Drug Delivery Systems for Cancer Therapy Market
Accounted market size in 2023	US$ 6551.3 million
Forecasted market size in 2030	US$ 7359.5 million
CAGR	1.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Embolization Particles – Drug Eluting Beads Polyvinyl Alcohol Particles Microspheres Gelatin-Based Embolization Devices Selective Internal Radiation Therapy Holmium-Based Microspheres Liquid Embolics – Onyx Other
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc., Terumo Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Drug Delivery Systems for Cancer Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Novel Drug Delivery Systems for Cancer Therapy Market growing?

Ans: The Novel Drug Delivery Systems for Cancer Therapy Market witnessing a CAGR of 1.7% during the forecast period 2024-2030.

What is the Novel Drug Delivery Systems for Cancer Therapy Market size in 2030?

Ans: The Novel Drug Delivery Systems for Cancer Therapy Market size in 2030 will be US$ 7359.5 million.

Who are the main players in the Novel Drug Delivery Systems for Cancer Therapy Market report?

Ans: The main players in the Novel Drug Delivery Systems for Cancer Therapy Market are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc., Terumo Corporation

What are the Application segmentation covered in the Novel Drug Delivery Systems for Cancer Therapy Market report?

Ans: The Applications covered in the Novel Drug Delivery Systems for Cancer Therapy Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Novel Drug Delivery Systems for Cancer Therapy Market report?

Ans: The Types covered in the Novel Drug Delivery Systems for Cancer Therapy Market report are Embolization Particles – Drug Eluting Beads, Polyvinyl Alcohol Particles, Microspheres, Gelatin-Based Embolization Devices, Selective Internal Radiation Therapy, Holmium-Based Microspheres, Liquid Embolics – Onyx, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Embolization Particles – Drug Eluting Beads

1.2.3 Polyvinyl Alcohol Particles

1.2.4 Microspheres

1.2.5 Gelatin-Based Embolization Devices

1.2.6 Selective Internal Radiation Therapy

1.2.7 Holmium-Based Microspheres

1.2.8 Liquid Embolics – Onyx

1.2.9 Other

1.3 Market by Application

1.3.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Perspective (2019-2030)

2.2 Novel Drug Delivery Systems for Cancer Therapy Growth Trends by Region

2.2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Region (2019-2024)

2.2.3 Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Region (2025-2030)

2.3 Novel Drug Delivery Systems for Cancer Therapy Market Dynamics

2.3.1 Novel Drug Delivery Systems for Cancer Therapy Industry Trends

2.3.2 Novel Drug Delivery Systems for Cancer Therapy Market Drivers

2.3.3 Novel Drug Delivery Systems for Cancer Therapy Market Challenges

2.3.4 Novel Drug Delivery Systems for Cancer Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Revenue

3.1.1 Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Revenue (2019-2024)

3.1.2 Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Novel Drug Delivery Systems for Cancer Therapy Revenue

3.4 Global Novel Drug Delivery Systems for Cancer Therapy Market Concentration Ratio

3.4.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2023

3.5 Novel Drug Delivery Systems for Cancer Therapy Key Players Head office and Area Served

3.6 Key Players Novel Drug Delivery Systems for Cancer Therapy Product Solution and Service

3.7 Date of Enter into Novel Drug Delivery Systems for Cancer Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Novel Drug Delivery Systems for Cancer Therapy Breakdown Data by Type

4.1 Global Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Type (2019-2024)

4.2 Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Type (2025-2030)

5 Novel Drug Delivery Systems for Cancer Therapy Breakdown Data by Application

5.1 Global Novel Drug Delivery Systems for Cancer Therapy Historic Market Size by Application (2019-2024)

5.2 Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Novel Drug Delivery Systems for Cancer Therapy Market Size (2019-2030)

6.2 North America Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2019-2024)

6.4 North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size (2019-2030)

7.2 Europe Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2019-2024)

7.4 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size (2019-2030)

8.2 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size (2019-2030)

9.2 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2019-2024)

9.4 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size (2019-2030)

10.2 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Advanced Medical Isotope Corporation

11.1.1 Advanced Medical Isotope Corporation Company Detail

11.1.2 Advanced Medical Isotope Corporation Business Overview

11.1.3 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction

11.1.4 Advanced Medical Isotope Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.1.5 Advanced Medical Isotope Corporation Recent Development

11.2 Bind Therapeutics

11.2.1 Bind Therapeutics Company Detail

11.2.2 Bind Therapeutics Business Overview

11.2.3 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Introduction

11.2.4 Bind Therapeutics Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.2.5 Bind Therapeutics Recent Development

11.3 Boston Scientific Corporation

11.3.1 Boston Scientific Corporation Company Detail

11.3.2 Boston Scientific Corporation Business Overview

11.3.3 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction

11.3.4 Boston Scientific Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.3.5 Boston Scientific Corporation Recent Development

11.4 BTG plc

11.4.1 BTG plc Company Detail

11.4.2 BTG plc Business Overview

11.4.3 BTG plc Novel Drug Delivery Systems for Cancer Therapy Introduction

11.4.4 BTG plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.4.5 BTG plc Recent Development

11.5 CeloNova BioSciences, Inc.

11.5.1 CeloNova BioSciences, Inc. Company Detail

11.5.2 CeloNova BioSciences, Inc. Business Overview

11.5.3 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction

11.5.4 CeloNova BioSciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.5.5 CeloNova BioSciences, Inc. Recent Development

11.6 Cook Medical, Inc.

11.6.1 Cook Medical, Inc. Company Detail

11.6.2 Cook Medical, Inc. Business Overview

11.6.3 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction

11.6.4 Cook Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.6.5 Cook Medical, Inc. Recent Development

11.7 Cospheric LLC

11.7.1 Cospheric LLC Company Detail

11.7.2 Cospheric LLC Business Overview

11.7.3 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Introduction

11.7.4 Cospheric LLC Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.7.5 Cospheric LLC Recent Development

11.8 Covidien, plc

11.8.1 Covidien, plc Company Detail

11.8.2 Covidien, plc Business Overview

11.8.3 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Introduction

11.8.4 Covidien, plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.8.5 Covidien, plc Recent Development

11.9 Eckert & Ziegler BEBIG

11.9.1 Eckert & Ziegler BEBIG Company Detail

11.9.2 Eckert & Ziegler BEBIG Business Overview

11.9.3 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Introduction

11.9.4 Eckert & Ziegler BEBIG Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.9.5 Eckert & Ziegler BEBIG Recent Development

11.10 EmboMedics, Inc.

11.10.1 EmboMedics, Inc. Company Detail

11.10.2 EmboMedics, Inc. Business Overview

11.10.3 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction

11.10.4 EmboMedics, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.10.5 EmboMedics, Inc. Recent Development

11.11 Kobo Products, Inc.

11.11.1 Kobo Products, Inc. Company Detail

11.11.2 Kobo Products, Inc. Business Overview

11.11.3 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction

11.11.4 Kobo Products, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.11.5 Kobo Products, Inc. Recent Development

11.12 Merit Medical Systems, Inc.

11.12.1 Merit Medical Systems, Inc. Company Detail

11.12.2 Merit Medical Systems, Inc. Business Overview

11.12.3 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction

11.12.4 Merit Medical Systems, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.12.5 Merit Medical Systems, Inc. Recent Development

11.13 Mo-Sci Corporation

11.13.1 Mo-Sci Corporation Company Detail

11.13.2 Mo-Sci Corporation Business Overview

11.13.3 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction

11.13.4 Mo-Sci Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.13.5 Mo-Sci Corporation Recent Development

11.14 Nanobiotix

11.14.1 Nanobiotix Company Detail

11.14.2 Nanobiotix Business Overview

11.14.3 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Introduction

11.14.4 Nanobiotix Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.14.5 Nanobiotix Recent Development

11.15 Polysciences, Inc.

11.15.1 Polysciences, Inc. Company Detail

11.15.2 Polysciences, Inc. Business Overview

11.15.3 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction

11.15.4 Polysciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.15.5 Polysciences, Inc. Recent Development

11.16 Sirtex Medical, Inc.

11.16.1 Sirtex Medical, Inc. Company Detail

11.16.2 Sirtex Medical, Inc. Business Overview

11.16.3 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Introduction

11.16.4 Sirtex Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.16.5 Sirtex Medical, Inc. Recent Development

11.17 Terumo Corporation

11.17.1 Terumo Corporation Company Detail

11.17.2 Terumo Corporation Business Overview

11.17.3 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Introduction

11.17.4 Terumo Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

11.17.5 Terumo Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Advanced Medical Isotope Corporation

BIND Therapeutics

Boston Scientific Corporation

BTG Plc

CeloNova BioSciences Inc.

Cook Medical Inc

Cospheric

Covidien

Eckert & Ziegler BEBIG

EmboMedics, Inc.

Kobo Products; Inc.

Merit Medical Systems Inc

List of Tables

Table 1. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Embolization Particles – Drug Eluting Beads

Table 3. Key Players of Polyvinyl Alcohol Particles

Table 4. Key Players of Microspheres

Table 5. Key Players of Gelatin-Based Embolization Devices

Table 6. Key Players of Selective Internal Radiation Therapy

Table 7. Key Players of Holmium-Based Microspheres

Table 8. Key Players of Liquid Embolics – Onyx

Table 9. Key Players of Other

Table 10. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2019-2024)

Table 14. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2025-2030)

Table 16. Novel Drug Delivery Systems for Cancer Therapy Market Trends

Table 17. Novel Drug Delivery Systems for Cancer Therapy Market Drivers

Table 18. Novel Drug Delivery Systems for Cancer Therapy Market Challenges

Table 19. Novel Drug Delivery Systems for Cancer Therapy Market Restraints

Table 20. Global Novel Drug Delivery Systems for Cancer Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Players (2019-2024)

Table 22. Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2023)

Table 23. Ranking of Global Top Novel Drug Delivery Systems for Cancer Therapy Companies by Revenue (US$ Million) in 2023

Table 24. Global 5 Largest Players Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Novel Drug Delivery Systems for Cancer Therapy Product Solution and Service

Table 27. Date of Enter into Novel Drug Delivery Systems for Cancer Therapy Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Type (2019-2024)

Table 31. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Type (2025-2030)

Table 33. Global Novel Drug Delivery Systems for Cancer Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Application (2019-2024)

Table 35. Global Novel Drug Delivery Systems for Cancer Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Application (2025-2030)

Table 37. North America Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 44. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 45. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 46. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 48. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 49. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 50. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 51. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 52. Advanced Medical Isotope Corporation Company Detail

Table 53. Advanced Medical Isotope Corporation Business Overview

Table 54. Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Product

Table 55. Advanced Medical Isotope Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 56. Advanced Medical Isotope Corporation Recent Development

Table 57. Bind Therapeutics Company Detail

Table 58. Bind Therapeutics Business Overview

Table 59. Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Product

Table 60. Bind Therapeutics Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 61. Bind Therapeutics Recent Development

Table 62. Boston Scientific Corporation Company Detail

Table 63. Boston Scientific Corporation Business Overview

Table 64. Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Product

Table 65. Boston Scientific Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 66. Boston Scientific Corporation Recent Development

Table 67. BTG plc Company Detail

Table 68. BTG plc Business Overview

Table 69. BTG plc Novel Drug Delivery Systems for Cancer Therapy Product

Table 70. BTG plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 71. BTG plc Recent Development

Table 72. CeloNova BioSciences, Inc. Company Detail

Table 73. CeloNova BioSciences, Inc. Business Overview

Table 74. CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product

Table 75. CeloNova BioSciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 76. CeloNova BioSciences, Inc. Recent Development

Table 77. Cook Medical, Inc. Company Detail

Table 78. Cook Medical, Inc. Business Overview

Table 79. Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product

Table 80. Cook Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 81. Cook Medical, Inc. Recent Development

Table 82. Cospheric LLC Company Detail

Table 83. Cospheric LLC Business Overview

Table 84. Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Product

Table 85. Cospheric LLC Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 86. Cospheric LLC Recent Development

Table 87. Covidien, plc Company Detail

Table 88. Covidien, plc Business Overview

Table 89. Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Product

Table 90. Covidien, plc Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 91. Covidien, plc Recent Development

Table 92. Eckert & Ziegler BEBIG Company Detail

Table 93. Eckert & Ziegler BEBIG Business Overview

Table 94. Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Product

Table 95. Eckert & Ziegler BEBIG Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 96. Eckert & Ziegler BEBIG Recent Development

Table 97. EmboMedics, Inc. Company Detail

Table 98. EmboMedics, Inc. Business Overview

Table 99. EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Product

Table 100. EmboMedics, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 101. EmboMedics, Inc. Recent Development

Table 102. Kobo Products, Inc. Company Detail

Table 103. Kobo Products, Inc. Business Overview

Table 104. Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Product

Table 105. Kobo Products, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 106. Kobo Products, Inc. Recent Development

Table 107. Merit Medical Systems, Inc. Company Detail

Table 108. Merit Medical Systems, Inc. Business Overview

Table 109. Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Product

Table 110. Merit Medical Systems, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 111. Merit Medical Systems, Inc. Recent Development

Table 112. Mo-Sci Corporation Company Detail

Table 113. Mo-Sci Corporation Business Overview

Table 114. Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Product

Table 115. Mo-Sci Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 116. Mo-Sci Corporation Recent Development

Table 117. Nanobiotix Company Detail

Table 118. Nanobiotix Business Overview

Table 119. Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Product

Table 120. Nanobiotix Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 121. Nanobiotix Recent Development

Table 122. Polysciences, Inc. Company Detail

Table 123. Polysciences, Inc. Business Overview

Table 124. Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product

Table 125. Polysciences, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 126. Polysciences, Inc. Recent Development

Table 127. Sirtex Medical, Inc. Company Detail

Table 128. Sirtex Medical, Inc. Business Overview

Table 129. Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product

Table 130. Sirtex Medical, Inc. Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 131. Sirtex Medical, Inc. Recent Development

Table 132. Terumo Corporation Company Detail

Table 133. Terumo Corporation Business Overview

Table 134. Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Product

Table 135. Terumo Corporation Revenue in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024) & (US$ Million)

Table 136. Terumo Corporation Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Type: 2023 VS 2030

Figure 3. Embolization Particles – Drug Eluting Beads Features

Figure 4. Polyvinyl Alcohol Particles Features

Figure 5. Microspheres Features

Figure 6. Gelatin-Based Embolization Devices Features

Figure 7. Selective Internal Radiation Therapy Features

Figure 8. Holmium-Based Microspheres Features

Figure 9. Liquid Embolics – Onyx Features

Figure 10. Other Features

Figure 11. Global Novel Drug Delivery Systems for Cancer Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 12. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Application: 2023 VS 2030

Figure 13. Hospitals Case Studies

Figure 14. Clinics Case Studies

Figure 15. Others Case Studies

Figure 16. Novel Drug Delivery Systems for Cancer Therapy Report Years Considered

Figure 17. Global Novel Drug Delivery Systems for Cancer Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Novel Drug Delivery Systems for Cancer Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Region: 2023 VS 2030

Figure 20. Global Novel Drug Delivery Systems for Cancer Therapy Market Share by Players in 2023

Figure 21. Global Top Novel Drug Delivery Systems for Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems for Cancer Therapy as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems for Cancer Therapy Revenue in 2023

Figure 23. North America Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2019-2030)

Figure 25. United States Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2019-2030)

Figure 29. Germany Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Novel Drug Delivery Systems for Cancer Therapy Market Share by Region (2019-2030)

Figure 37. China Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2019-2030)

Figure 45. Mexico Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Market Share by Country (2019-2030)

Figure 49. Turkey Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Novel Drug Delivery Systems for Cancer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Advanced Medical Isotope Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 52. Bind Therapeutics Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 53. Boston Scientific Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 54. BTG plc Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 55. CeloNova BioSciences, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 56. Cook Medical, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 57. Cospheric LLC Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 58. Covidien, plc Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 59. Eckert & Ziegler BEBIG Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 60. EmboMedics, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 61. Kobo Products, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 62. Merit Medical Systems, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 63. Mo-Sci Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 64. Nanobiotix Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 65. Polysciences, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 66. Sirtex Medical, Inc. Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 67. Terumo Corporation Revenue Growth Rate in Novel Drug Delivery Systems for Cancer Therapy Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions